Medicine guide
EVIPLERA
As listed in the register: EVIPLERA 200 mg/25 mg/245 mg, comprimé pelliculé
200 mg + 300 mg + 27,5 mg · comprimé pelliculé
- Prescription only
- Made by
- GILEAD SCIENCES IRELAND UC (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | GILEAD SCIENCES IRELAND UC (IRLANDE) |
|---|---|
| Active substance | Emtricitabine + Fumarate De Ténofovir Disoproxil + Rilpivirine (Chlorhydrate De) |
| Strength | 200 mg + 300 mg + 27,5 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | prescription initiale hospitalière annuelle · liste I · renouvellement non restreint |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/11/737 |
| Name in the register | EVIPLERA 200 mg/25 mg/245 mg, comprimé pelliculé |
| Packs | flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s) |
| CIS | 63578537 |
| CIP13 | 3400921947359 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).